Market Value2,681,037,164
Total Holdings63
File Date2025-02-14
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
SLN / Silence Therapeutics plc - Depositary Receipt (Common Stock)
FDMT / 4D Molecular Therapeutics, Inc.
CNTX / Context Therapeutics Inc.
AUTL / Autolus Therapeutics plc - Depositary Receipt (Common Stock)
VIGL / Vigil Neuroscience, Inc.
NMRA / Neumora Therapeutics, Inc.
NMRA / Neumora Therapeutics, Inc. Call
BBIO / BridgeBio Pharma, Inc.
SWTX / SpringWorks Therapeutics, Inc.
GERN / Geron Corporation
EWTX / Edgewise Therapeutics, Inc.
SYRS / Syros Pharmaceuticals, Inc.
ALEC / Alector, Inc.
AXSM / Axsome Therapeutics, Inc.
AXSM / Axsome Therapeutics, Inc. Call
IMCR / Immunocore Holdings plc - Depositary Receipt (Common Stock)
XENE / Xenon Pharmaceuticals Inc.
NRIX / Nurix Therapeutics, Inc.
BCAX / Bicara Therapeutics Inc.
ENGN / enGene Holdings Inc.
SEPN / Septerna, Inc.
BCYC / Bicycle Therapeutics plc - Depositary Receipt (Common Stock)
AVTX / Avalo Therapeutics, Inc.
GH / Guardant Health, Inc.
ETNB / 89bio, Inc.
GPCR / Structure Therapeutics Inc. - Depositary Receipt (Common Stock)
PTGX / Protagonist Therapeutics, Inc.
ABVX / ABIVAX Société Anonyme - Depositary Receipt (Common Stock)
ZURA / Zura Bio Limited
APLS / Apellis Pharmaceuticals, Inc.
OLMA / Olema Pharmaceuticals, Inc.
XNCR / Xencor, Inc.
IMVT / Immunovant, Inc.
SAVA / Cassava Sciences, Inc. Put
RARE / Ultragenyx Pharmaceutical Inc.
IVVD / Invivyd, Inc.
CYBN / Cybin Inc.
VRDN / Viridian Therapeutics, Inc.
MBX / MBX Biosciences, Inc.
ITCI / Intra-Cellular Therapies, Inc.
FATE / Fate Therapeutics, Inc.
ARGX / argenx SE - Depositary Receipt (Common Stock)
ALKS / Alkermes plc
KYMR / Kymera Therapeutics, Inc.
ANRO / Alto Neuroscience, Inc.
MGX / Metagenomi, Inc.
TVTX / Travere Therapeutics, Inc.
RNA / Avidity Biosciences, Inc.
SRRK / Scholar Rock Holding Corporation
ALLK / Allakos Inc.
AKRO / Akero Therapeutics, Inc.
UPB / Upstream Bio, Inc.
RAPT / RAPT Therapeutics, Inc.
DVAX / Dynavax Technologies Corporation
ORKA / Oruka Therapeutics, Inc.
KURA / Kura Oncology, Inc.
EDIT / Editas Medicine, Inc.
PRTA / Prothena Corporation plc
TGTX / TG Therapeutics, Inc.
NKTR / Nektar Therapeutics
NVAX / Novavax, Inc.
TERN / Terns Pharmaceuticals, Inc.
VRNA / Verona Pharma plc - Depositary Receipt (Common Stock)
PYXS / Pyxis Oncology, Inc.
OKUR / OnKure Therapeutics, Inc.
HRMY / Harmony Biosciences Holdings, Inc.
INO / Inovio Pharmaceuticals, Inc.
DYN / Dyne Therapeutics, Inc.
RGLS / Regulus Therapeutics Inc.
ANIP / ANI Pharmaceuticals, Inc.
IONS / Ionis Pharmaceuticals, Inc.
CNTA / Centessa Pharmaceuticals plc - Depositary Receipt (Common Stock)
CLYM / Climb Bio, Inc.
CYTK / Cytokinetics, Incorporated
OCUL / Ocular Therapeutix, Inc.
PLRX / Pliant Therapeutics, Inc.
MNMD / Mind Medicine (MindMed) Inc.
APGE / Apogee Therapeutics, Inc.
GMAB / Genmab A/S - Depositary Receipt (Common Stock)
NTLA / Intellia Therapeutics, Inc.
KRRO / Korro Bio, Inc.
RLMD / Relmada Therapeutics, Inc.
GLPG / Galapagos NV - Depositary Receipt (Common Stock)
ALGS / Aligos Therapeutics, Inc.
CLDX / Celldex Therapeutics, Inc.
SYRE / Spyre Therapeutics, Inc.